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ABSTRACT
Background: The purpose of the present study is to investigate the association of nonal-
coholic fatty liver disease (NAFLD) with the doppler waveform pattern of hepatic veins 
and portal vein doppler indices.
Objectives: This assay may be useful in evaluating the natural course of NAFLD and 
monitor treatment eﬃcacy on follow-up.
Patients and Methods: This case control study was performed in 31 patients with NAFLD 
and 31 normal healthy adults who served as the control group. The patients presented 
with elevated liver enzymes levels (ALT/AST) and hyperechogenic livers in the B-mode 
ultrasonography examination. Eleven patients had a liver biopsy. After an 8-hour fast, 
B-mode and duplex doppler ultrasonography were performed, and the waveform pat-
terns of the right hepatic vein, portal vein diameter, grade of fatty liver, portal vein 
pulsatility index (VPI), and mean ﬂow velocity (MFV) were measured.
Results: VPI and MFV values were 0.42 ± 0.92 and 17.27 ± 5.34 cm/second, respectively, in 
the control group and 0.25 ± 0.50 and 12.82 ± 4.32 cm/second in patients with NAFLD (P 
< 0.01). The frequency of abnormal hepatic vein doppler waveform patterns (biphasic 
or monophasic) was signiﬁcantly higher in patients with NAFLD (55.2%) versus control 
subjects (3.2%) (P < 0.001). There was no correlation between the degree of fat inﬁltra-
tion and VPI (P = 0.714), MFV (P = 0.911), or hepatic vein waveform pattern (P = 0.197). We 
found no correlation between liver enzyme levels and MFV or VPI. However, the rate of 
abnormal hepatic vein was higher in patients with enzyme levels that exceeded twice 
the normal value (P = 0.05).
Conclusions: Patients with NAFLD have a high rate of abnormal hepatic vein doppler 
waveform patterns, and decreased VPI and MFV are suggestive of reduced vascular 
compliance in the liver. Elevated liver enzymes levels do not inﬂuence VPI or MFV, but 
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1. Background
Nonalcoholic fatty liver disease (NAFLD) is the most 
common cause of abnormal liver function tests in 
hepatology practices. NAFLD aﬀects approximately 15% 
to 25% of the general population worldwide (1) and is 
characterized by lipid deposition within the hepatocytes 
with no history of excessive alcohol consumption (2). 
NAFLD is associated with central obesity, type 2 diabetes, 
dyslipidemia, high blood pressure, and metabolic 
syndrome (MetS) (3). NAFLD is a spectrum that ranges 
from pure fatty liver to nonalcoholic steatohepatitis 
(NASH). Although it had been considered to be benign, 
recent studies have shown that liver ﬁbrosis, cirrhosis, 
and liver failure can develop in patients with NAFLD. In 
15% to 50% of cases, ﬁbrosis exists at the initial diagnosis 
(4). Liver ultrasonography is a noninvasive modality that 
is widely used to diagnose NAFLD and has a sensitivity of 
82% to 89% and speciﬁcity of 93% in detecting fatty liver 
inﬁltration (5). It is based on increased liver parenchymal 
echogenicity. Sonography of fatty inﬁltration can vary, 
depending on the amount of fat and whether deposits 
are diﬀuse or focal. Diﬀuse steatosis can be:
• Mild (grade 1): Minimal diﬀuse increase in hepatic 
echogenicity; diaphragm and intrahepatic vessel borders 
are visualized normally.
•  Moderate  (grade  2):  Moderate  diﬀuse  increase  in 
hepatic echogenicity; slightly impaired visualization of 
intrahepatic vessels and diaphragm.
•  Severe  (grade  3):  Marked  increase  in  hepatic 
echogenicity and poor penetration of the posterior 
segment of the right diaphragm (6).
Duplex doppler ultrasonography has become an 
important diagnostic method in the noninvasive 
evaluation of hepatic vasculature and certain hepatic 
parenchymal diseases (7). Reduced hepatic blood ﬂow is 
observed in experimental animals with fatty deposition 
in the liver, and similar data are expected in humans 
(4). Recent articles suggest that NAFLD can change the 
waveform pattern of hepatic veins (7-9) and portal vein 
doppler indices (10, 11). NAFLD can also decrease hepatic 
artery resistance index (12). Hepatic vein pulsatility is also 
ﬂattened in obese patients, correlating with the grade of 
hepatosteatosis. The body habitus itself does not have an 
independent eﬀect on hepatic venous waveform (13).
2. Objectives
In this study, we investigated the association of 
nonalcoholic fatty liver disease with the doppler 
waveform pattern of the hepatic veins and portal vein 
doppler indices. We also examined the relationship 
between the degree of fatty inﬁltration in the liver 
and the waveform pattern of hepatic veins, portal vein 
pulsatility index, and mean ﬂow velocity. This assay can 
be helpful in diagnosing NAFLD and its eﬀects on liver 
hemodynamics, evaluating the natural course of NAFLD, 
and monitoring treatment eﬃcacy on follow-up.
3. Patients and Methods
This case control study was performed from September 
2009 to June 2010 in patients who were referred to the 
Gastrointestinal and liver diseases research center 
(GLDRC) of Guilan university of medical science 
and a private GI clinic in Rasht (the capital city of 
Guilan province) with elevated liver enzymes and 
hyperechogenic liver by B-mode ultrasonography. Other 
causes of liver enzyme elevation, such as alcoholic 
hepatitis, autoimmune hepatitis, viral hepatitis, 
Wilson’s disease, α1 antitrypsin deﬁciency, drug-
induced hepatitis, and hemochromatosis, were ruled 
out. Patients with heart failure were excluded. Eleven 
patients had undergone a liver biopsy due to prolonged 
NAFLD. The control group was selected from healthy 
volunteers (Razi hospital personnel) after an evaluation, 
with no evidence of fatty liver by ultrasonography and 
normal liver enzyme levels. Cases with heart failure were 
excluded from the control group. The study protocol was 
approved by the ethics committee of the Gastrointestinal 
and Liver Diseases Research Center of Guilan University 
of Medical Science, and written informed consents 
(per the Helsinki declaration) was obtained from each 
participant. The study population included 31 patients 
(25 men and 6 women; mean age 40.65 ± 8.90 years, 
range 24–59 years) who were referred to the Hepatology 
Clinic of Razi Hospital Rasht, Iran, and 31 subjects in the 
control group (24 men and 7 women; mean age 38.19 ± 
11.98 years, range 22–61 years). After 8 hours of fasting, 
all patients and control subjects were examined by 
B-mode and duplex doppler ultrasonography using a 
3.5 MHz convex array transducer (Sonix OP, Canada) in 
the supine position by the same expert radiologist. The 
degree of fatty inﬁltration was graded from 0 to 3 with 
regard to increasing degrees of hepatic echogenicity 
with poorer visualization of the intrahepatic vessels 
and diaphragm, indicating absent, mild, moderate, and 
severe hepatosteatosis (6).
Evaluation of the hepatic vein was performed in the 
left decubitus position using a right lateral intercostal 
approach during deep inspiration. The sample volume 
was positioned in the right hepatic vein 3-5 cm away 
from the inferior vena cava to prevent any inﬂuence 
of waveform alterations of the inferior vena cava and 
was adjusted to cover at least two-thirds of the vessel 
diameter (7). The spectral analysis was recorded for at Hepat Mon. 2011;11(9):740-744
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least 2-3 cycles, and the doppler angle was set to less than 
60 degrees. We chose the right hepatic vain to avoid the 
eﬀects of cardiac motion on vein pulsatility (14). The ﬂow 
pattern of the right hepatic vein was classiﬁed as triphasic 
(which is a regular pattern), biphasic, and monophasic. 
The triphasic wave pattern consisted of 2 antegrade peaks, 
followed by a short reversed ﬂow; the biphasic waveform 
was deﬁned as the loss of reversed ﬂow and decreased 
amplitude of oscillations. The monophasic waveform 
was deﬁned as a continuous ﬂat wave without periodicity 
(13). The portal vein examination was performed in the 
left decubitus position with the arms raised above the 
head. The sample volume was positioned in the main 
portal vein, proximal to the bifurcation to cover at least 
two-thirds of the vessel diameter, and the doppler angle 
was set to less than 60 degrees (10). The peak maximum 
velocity (Vmax), peak minimum velocity (Vmin), mean ﬂow 
velocity (MFV), and portal vein diameter were measured, 
and the vein pulsatility index (VPI) VPI = Vmax – Vmin/
Vmax (15).
A pathologist without any knowledge of the patient’s 
data evaluated the histological ﬁndings, and the 
nonalcoholic fatty liver disease activity score (NAS) 
(16) and stage were reported. The scoring system of 
NASH, developed by Brunt and colleagues, has been 
widely accepted. It uniﬁes the lesions of steatosis and 
necroinﬂammation into a grade and those of ﬁbrosis 
into a stage. The score is deﬁned as the sum of the scores 
for steatosis (0-3), lobular inﬂammation (0-3), and 
ballooning (0-2), thus ranging from 0 to 8; ﬁbrosis stage 
ranges from 0 to 4. NASH was deﬁned as an NAS of ≥ 5, 
“borderline NASH” as NAS of 3 or 4, and “not diagnostic 
of NASH” as NAS of < 3 (16). The fatty liver grading scale 
is based on ultrasonography The patients were divided 
to 2 subgroups, based on the liver enzyme levels: those 
with ALT levels less than twice the normal value (normal 
range = 35 IU/L) and more than twice the normal value 
(17). Then, the doppler parameters were determined for 
each group. The statistical analysis was performed using 
SPSS for Windows, version 16.0. The distribution of data 
was analyzed by one-sample Kolmogorov-Smirnov test. 
Continuous variables were expressed as mean ± SD and as a 
percentage (%) for categorical variables. Fisher’s exact test 
was used as appropriate to analyze categorical variables, 
and Student’s t-test was used to analyze continuous 
variables. Fisher’s exact test was used to demonstrate the 
relationship between fatty liver grade and the presence 
of an abnormal hepatic vein Doppler waveform; one-way 
ANOVA was used to analyze the relationship between 
fatty liver grade and quantitative variables. All tests of 
signiﬁcance were two-tailed, and P values that were less 
than 0.05 were considered statistically signiﬁcant.
4. Results
The fatty liver was grade 1 in 9 patients (29%), grade 2 in 
16 patients (52%), and grade 3 in 6 patients (19%). Mean BMI 
(body mass index) in the patients (29.23 ± 3.35 Kg/M2) was 
signiﬁcantly higher than in the control group (23.79 ± 
4.31 Kg/M2) (P < 0.001). There was no signiﬁcant diﬀerence 
in mean portal vein diameter between patients (10.77 ± 
1.51 mm) and controls (10.35 ± 1.57 mm) (P = 0.379). The 
doppler ﬂow pattern in the hepatic vein was triphasic 
in 17 (54.8%), biphasic in 10 (32.3%), and monophasic in 4 
(12.9%) subjects with NAFLD and triphasic in 30 (96.8%) and 
biphasic in 1 (3.2%) patient in the control group; none had 
a monophasic wave pattern. The frequency of abnormal 
hepatic vein waveform (biphasic or monophasic) was 
signiﬁcantly higher in patients with NAFLD than in 
controls (P < 0.001, OR = 23.33). However, we found no 
correlation between the degree of fat inﬁltration and 
abnormal hepatic vein waveform pattern (P = 0.197) 
(Table 1). The MFV was 12.82 ± 4.32 cm/second in patients 
and 17.27 ± 5.34 cm/second in the control group (P < 0.01), 
(Table 2). There was no signiﬁcant diﬀerence in mean MFV 
between fatty liver grades (P = 0.911) (Table 3). VPI was 0.25 
± 0.50 in patients and 0.42 ± 0.92 in control subjects (P 
< 0.001) (Table 2). There was no signiﬁcant diﬀerence in 
mean VPI between fatty liver grades (P = 0.714) (Table 3). 
Liver enzyme levels were more than twice the normal 
value in 13 patients (41.9%). VPI and MFV values were 
0.27 ± 0.54 and 12.18 ± 4.32, respectively, in the minor 
Grade I, 
No. (%) (n = 9)
Grade II, 
No. (%) (n = 16)
Grade III, 
No. (%) (n = 6)
Triphasic 7 (77.8) 8 (50) 2 (33.3)
Biphasic 1 (11.1) 7 (43.8) 2 (33.3)
Monophasic 1 (11.1) 1 (6.2) 2 (33.3)
Table 1. Distribution of the Right Hepatic Vein Flow Pattern According to 
Ultrasonographic Grading of the Fatty Inﬁltration of the Liver a
a There is no correlation between the degree of fat inﬁltration and abnormal 
hepatic vein waveform pattern (biphasic or monophasic) (P = 0.197)
Control (n = 31) NAFLD (n = 31) P value
MFV b (cm/sec) 5.34 ± 17.27 12.82 ± 4.32 < 0.01
VPI b 0.92 ± 0.42 0.50 ± 0.25 < 0.001
Table 2. The Portal Vein Pulsatility Index (VPI) and Mean Flow Velocity (MFV) 
in Patients with NAFLD and Control Group a
a VPI and MFV are signiﬁcantly lower in patients with NAFLD than control 
group.
b Abbreviations: MFV, Mean Flow Velocity; VPI, Vein Pulsatility Index
Grade I




 (n = 6)
P value
MFV b (cm/sec) 13.29 ± 5.01 12.77 ± 4.17 12.28 ± 4.30 0.911
VPI b 0.26 ± 0.28 0.25 ± 0.64 0.24 ± 0.11 0.714
Table 3. The Portal Vein Pulsatility Index (VPI) and Mean Flow Velocity (MFV) 
According to Ultrasonographic Grading of the Fatty Inﬁltration of the Liver 
and Control Group a
a No signiﬁcant correlation was found between the grade of fatty liver and 
VPI and MFV 
b Abbreviations: MFV, Mean Flow Velocity; VPI, Vein Pulsatility IndexHepat Mon. 2011;11(9):740-744
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enzyme elevation group and 0.24 ± 0.43 and 13.60 ± 4.34, 
respectively, in patients with liver enzyme levels over 
twice the normal value. (P = 0.734 for VPI and P = 0.970 
for MFV). The doppler ﬂow pattern in the hepatic vein 
was abnormal (biphasic or monophasic) in 5 patients 
(27.8%) in the minor enzyme elevation group and 9 
patients (69.2%) in the other group. The rate of abnormal 
hepatic vein waveform (biphasic or monophasic) was 
signiﬁcantly higher in patients with enzyme levels more 
than twice the normal value than in those with levels 
less than twice the normal value (P = 0.05, OR = 5.85). In 
11 patients who underwent liver biopsy, the nonalcoholic 
fatty liver disease activity score was 0-2 in 3 patients, 3-4 in 
3 patients, and 5-8 in 5 patients. The pathological ﬁbrosis 
stage was 0 in 8 and 1 in 3 patients. In patients with 
biopsy-proven fatty liver, the mean portal vein diameter 
was 10.59 ± 1.24 mm, VPI was 0.28 ± 0.06, and MFV was 
13.89 ± 5.10. The doppler ﬂow pattern in the hepatic vein 
was triphasic in 7 (64%) and biphasic in 4 (36%) patients, 
and none had a monophasic pattern.
5. Discussion
There was no signiﬁcant diﬀerence in gender (P = 0.755) 
or age (P = 0.364) between case and control groups; thus, 
they did not inﬂuence the study results. The hepatic veins 
characteristically have a triphasic wave form, which 
reﬂects right atrial and inferior vena caval pressures. 
The pressure of the right atrium, respiration, and the 
compliance of the hepatic parenchyma inﬂuence the 
spectral wave of hepatic veins; thus, cardiovascular 
and liver parenchymal diseases, such as cirrhosis, liver 
transplant rejection, and Budd Chiari syndrome, can 
alter triphasic waveform patterns. Nontriphasic patterns 
are detected in normal populations as well (7). Oguzkurt 
et al. reported that patients with fatty liver had a high rate 
of abnormal hepatic vein doppler waveform patterns, 
which can be biphasic or monophasic, but they found no 
correlation between the degree of fat inﬁltration and the 
hepatic vein waveform pattern (7). Herbay et al. and Uzun 
et al. veriﬁed the eﬀect of fatty inﬁltration on hepatic 
vein wave patterns. In a study by Uzun et al. sonographic 
grade of fatty inﬁltration of the liver correlated inversely 
with phasicity of hepatic venous ﬂow (8, 9). In this study, 
we noted dampening of the hepatic vein spectrum 
(biphasic or monophasic) in patients with NAFLD, which 
might be due to hypertrophied hepatocytes that cause 
hepatic vein compression and subsequently decrease 
vein phasicity. We found no relation between the severity 
of fat deposition and abnormal hepatic vein wave 
patterns. Portal venous ﬂow is classically described as 
being continuous in healthy subjects. Feeble pulsatility 
in rhythm with the cardiac cycle, however, has been noted 
in normal subjects. Marked pulsatility in the portal vein 
ﬂow has been interpreted as a sign of congestive heart 
failure. Marked modulation of portal blood ﬂow has 
been explained by exaggerated phasic pressure changes, 
transmitted from the right atrium (15).
In a report by Balci et al. venous pulsatility index (VPI) 
and mean ﬂow velocity (MFV) of the portal vein were 
signiﬁcantly lower in patients with diﬀuse fatty liver 
inﬁltration; these indices decreased as the severity 
of fatty inﬁltration increased (11). Erdogmus et al. 
supported these ﬁndings in a similar study (10). In our 
study, VPI and MFV were signiﬁcantly lower in patients 
with NAFLD than in the control group, which could have 
been caused by impaired vascular compliance due to 
fat deposition in hepatocytes. There was no correlation 
between sonographic grading of fatty livers and MFV 
and VPI values. In all of these investigations (10, 11) and 
our study, fatty liver inﬁltration was graded based on 
the ultrasonographic appearance changes, except for 
Oguzkurt et al. (7), who used an enhanced CT scan.  
However, ultrasonography has high sensitivity 
and speciﬁcity in detecting fatty liver inﬁltration 
(5); the grading of fatty liver is subjective and can 
lead to interobserver disagreement. In addition, 
ultrasonography is unable to assess ﬁbrosis, necrosis, 
and inﬂammation, which could inﬂuence MFV, VPI, and 
hepatic vein ﬂow patterns, requiring liver biopsy to 
examine these conditions. Therefore, the diﬀerences in 
the eﬀect of the severity of fatty liver on MFV, VPI, and 
hepatic vein spectrum might be due to these limitations. 
The number of patients could be another limitation (only 
6Grade III patients in this study), and another study with 
more cases may be required. We found no correlation 
between liver enzyme levels and MFV and VPI. However, 
the rate of abnormal hepatic vein was higher in patients 
with enzyme levels more than twice the normal value. 
Because the number of biopsy-proven patients was 
not adequate for statistical analysis, another study on 
the pathology results should be performed with more 
participants.
Patients with diﬀuse fatty liver inﬁltration have a 
higher rate of abnormal hepatic vein doppler waveform 
patterns (biphasic or monophasic) than the normal 
population, and VPI and MFV values are signiﬁcantly 
lower than in healthy subjects. These ﬁndings suggest 
reduced vascular compliance in the liver in NAFLD. We 
found no signiﬁcant correlation between sonographic 
fatty liver grade and MFV, VPI, or the rate of abnormal 
hepatic vein waveform. Elevated liver enzyme levels do 
not inﬂuence VPI and MFV, but patients with abnormal 
enzymes have higher rates of abnormal hepatic vein 
doppler waveform patterns.
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